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Abstract	29 
Background	30 Progression	of	Alzheimer’s	disease	is	thought	initially	to	depend	on	rising	amyloidβ	and	31 its	synaptic	interactions.	Transgenic	mice	(TASTPM;	APPSwe/PSEN1M146V)	show	altered	32 synaptic	transmission,	compatible	with	increased	physiological	function	of	amyloidβ,	33 before	plaques	are	detected.	Recently,	the	importance	of	microglia	has	become	apparent	34 in	the	human	disease.	Similarly,	TASTPM	show	a	close	association	of	plaque	load	with	35 upregulated	microglial	genes.	36 
	37 
Methods	38 CA1	Synaptic	transmission	and	plasticity	were	investigated	using	in	vitro	39 electrophysiology.	Migroglial	relationship	to	plaques	was	examined	with	40 immunohistochemistry.	Behaviour	was	assessed	with	a	forced-alternation	T-maze,	open	41 field,	light/dark	box	and	elevated	plus	maze.	42 	43 
Findings	44 The	most	striking	finding	is	the	increase	in	microglial	numbers	in	TASTPM,	which,	like	45 synaptic	changes,	begins	before	plaques	are	detected.	Further	increases	and	a	reactive	46 phenotype	occur	later,	concurrent	with	development	of	larger	plaques.	Long-term	47 potentiation	is	initially	enhanced	at	pre-plaque	stages	but	decrements	with	the	initial	48 appearance	of	plaques.	Finally,	despite	altered	plasticity,	TASTPM	have	little	cognitive	49 deficit,	even	with	a	heavy	plaque	load,	although	they	show	altered	non-cognitive	50 behaviours.	51 	52 
Interpretation	53 The	pre-plaque	synaptic	changes	and	microglial	proliferation	are	presumably	related	to	54 low,	non-toxic	amyloidβ	levels	in	the	general	neuropil	and	not	directly	associated	with	55 plaques.	However,	as	plaques	grow,	microglia	proliferate	further,	clustering	around	56 plaques	and	becoming	phagocytic.	Like	in	humans,	even	when	plaque	load	is	heavy,	57 without	development	of	neurofibrillary	tangles	and	neurodegeneration,	these	58 alterations	do	not	result	in	cognitive	deficits.	Behaviours	are	seen	that	could	be	59 consistent	with	pre-diagnosis	changes	in	the	human	condition.	60 	61 
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Research	in	context	69 
Evidence	before	this	study	70 There	is	a	large	body	of	research	examining	many	aspects	of	phenotypes	associated	with	71 mouse	models	of	Alzheimer’s	disease	–	a	PubMed	search	for	the	terms	Alzheimer*	AND	72 mouse	returns	in	excess	of	21000	articles.	However,	there	are	few	systematic	articles	73 pulling	together	pathological,	functional	(electrophysiological),	and	behavioural	74 analyses	across	the	life-span	of	such	models.		There	is	also	a	number	of	conflicting	75 outcomes,	for	example	reports	of	impaired	versus	enhanced	synaptic	plasticity;	76 cognitive	impairments	or	not.	77 	78 Recently,	the	importance	of	microglia	in	Alzheimer’s	disease	has	come	to	the	fore	in	79 human	Genome	Wide	Association	Studies	(GWAS),	with	variants	of	a	number	of	80 microglial	genes	identified	as	risk-factors	for	developing	the	disease.		Interestingly,	we	81 have	recently	reported	that	Trem2	and	other	genes	identified	as	risk-factors	in	humans	82 are	strongly	up	regulated	in	close	association	to	plaque	development	in	the	mouse	83 model	used	in	this	study.	Moreover,	this	previous	study	predicted	two	of	the	most	84 recently	identified	genes	that	were	identified	in	GWAS	since	the	publication	of	our	85 paper.	86 	87 We	have	previously	used	this	model	to	identify	the	earliest	synaptic	changes	and	shown	88 changes	in	release	of	glutamate,	the	primary	excitatory	neurotransmitter	in	the	brain,	to	89 occur	even	before	plaques	are	detectable.	90 	91 
Added	value	of	this	study	92 By	studying	this	transgenic	mouse	model	of	Alzheimer’s	disease,	throughout	the	93 development	of	plaques,	from	prior	to	detection	through	to	heavy	plaque	loads,	we	have	94 
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been	able	to	identify	a	clear	time	course	of	key	phenotypic	changes	associated	with	early	95 disease.	In	particular,	this	study	identifies	the	very	early	changes	in	microglia	and	can	96 separate	the	time	course	of	the	microglial	phenotype.	In	addition,	we	detail	the	changes	97 in	synaptic	plasticity	over	time	and	importantly	identify	that,	like	in	humans	in	the	98 absence	of	Tau	tangles	or	neurodegeneration,	considerable	synaptic	changes	can	occur	99 and	a	heavy	plaque	load	without	resulting	in	substantial	cognitive	loss.	100 
	101 
Implications	of	all	the	available	evidence	102 Our	data	indicate	that	rising	amyloid	beta	prior	to	detectable	plaque	deposition	results	103 in	changes	in	synaptic	function	that	likely	reflects	an	enhanced	physiological	effect	of	104 amyloid	beta.	At	this	stage,	microglia	proliferate	but	do	not	activate.	Once	plaques	begin	105 to	appear,	microglia	migrate	to	surround	the	plaque	and	become	phagocytic,	likely	106 targeting	dystrophic	synapses	and	neurites	caused	by	the	cloud	of	highly-toxic	amyloid	107 beta	around	the	plaque.	Similarly	to	humans,	who	have	plaques	but	no	tangles	and	have	108 yet	to	develop	substantial	neurodegeneration,	cognitive	deficits	are	not	seen,	even	with	109 a	heavy	plaque	load;	behavioural	changes	are	limited	to	anxiety-like	effects.	110 	111 This	investigation	of	the	parallel	time-course	of	events	highlights	the	probability	that,	if	112 progression	of	disease	can	be	reversed	or	slowed	early	enough,	before	Tau	tangles	and	113 substantial	neurodegeneration	occur,	the	symptoms	of	cognitive	decline	could	be	very	114 largely	avoided.	Moreover,	it	suggests	that	the	substantial	increases	in	microglia	number	115 and	upregulation	of	their	specific	gene	expression	in	association	with	plaques,	is	not	116 associated	with	cognitive	loss	and	may	indeed	be	protective.	 	117 
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Introduction	118 The	onset	and	progression	of	Alzheimer’s	disease	(AD)	is	most	likely	initiated	by	119 environmental	factors	interacting	with	predisposed	genetic	risks,	many	of	which	have	120 now	been	identified	in	genome-wide	association	studies	(see	reference	1	for	review).	In	121 familial	AD,	an	inherited	mutation	causes	rising	amyloidβ	(Aβ)	levels	and	it	has	long	122 been	established	that	this	triggers	a	chain	of	events	that	leads	to	the	eventual	cognitive	123 decline.[2]	In	sporadic	AD,	it	is	highly	likely	that	initial	triggering	events	(genetic	and/or	124 environmental)	also	lead	to	rising	Aβ	and	that,	like	in	the	familial	disease,	Aβ	levels	125 represent	an	essential	contributor	to	the	ongoing	pathology	and	eventual	126 neurodegeneration.[3,	4]	Under	normal	physiological	conditions,	Aβ	acts	as	an	activity-127 dependent	synaptic	modulator	which,	when	released	from	presynaptic	neuronal	128 terminals,	increases	probability	of	glutamate	release.[5]	Inappropriate	neuronal	activity	129 and/or	genetic	imbalances	in	production	versus	clearance	mechanisms	may	thus	lead	to	130 a	prolonged	rise	in	Aβ	levels,[6]	enabling	the	formation	of	Aβ	oligomers	and	deposition	of	131 plaques.	It	is	notable	that	restoring	γ-frequency	oscillations	in	transgenic	mouse	models	132 expressing	genes	harbouring	familial	mutations	associated	with	familial	AD,	reduces	Aβ	133 load[7]	and	restores	cognitive	deficits.[8]	134 	135 Animal	models	for	AD	have	generally	depended	on	transgenic	expression,	or	more	136 recently	knock-in	of	the	gene	variants	that	cause	the	familial	dominantly	inherited	forms	137 of	the	disease,	particularly	amyloid	precursor	protein	(APP)	or	presenilin	1	or	2	(PSEN1	138 or	PSEN2).	This	is	an	effective	approach	for	initiating	the	rise	in	Aβ	and	the	deposition	of	139 plaques,	albeit	by	a	different	trigger	than	in	sporadic	AD.	According	to	the	‘amyloid	140 hypothesis’,	in	the	human	disease,	rise	in	Aβ	and	plaque	deposition	is	suggested	to	lead	141 to	altered	neuronal	ionic	homeostasis	and	increased	oxidative	stress.	Together,	these	142 may	result	in	increased	kinase	activity	on	microtubule-associated	protein	Tau,	resulting	143 in	Tau	hyperphosphorylation	and	neurofibrillary	tangle	formation.[9]	The	exact	144 mechanisms	linking	Aβ	and	Tau	phosphorylation	remain	unclear	and	unfortunately,	145 despite	the	initiation	of	Aβ	pathology,	mouse	models	with	genes	for	familial	Alzheimer’s	146 disease	do	not	completely	recapitulate	these	later	events.	As	documented	in	the	initial	147 descriptions	of	the	TASTPM	mice,	which	are	hemizygous	for	both	human	APPSwe	and	148 human	PSEN1M146V	,	plaques	are	first	detected	at	approximately	4	months	of	age	and	a	149 considerable	plaque	load	develops	by	8	months.[10,	11]	Furthermore,	phosphorylation	of	150 
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Tau	is	detectable	in	the	dystrophic	neurites	around	plaques,[11]	recently	suggested	to	be	151 an	early	stage	of	Tau	pathology.[12]	An	inability	to	extinguish	hippocampal-dependent	152 contextual	fear	conditioning	at	4	months	when	plaques	are	first	detected[13,	14]	and	a	153 deficit	in	novel	object	recognition	at	6	months,[15]	have	also	been	reported.	154 	155 We	recently	reported	alterations	in	synaptic	transmission	preceding	the	detection	of	156 plaques,	manifesting	as	a	loss	of	spontaneous	action	potentials	in	Schaffer	collateral	157 axons	and	a	concomitant	increase	in	probability	of	glutamate	release.[16]	Importantly,	we	158 have	demonstrated	an	almost	1:1	correlation	of	plaque	load	with	expression	of	a	module	159 of	microglial	genes	throughout	the	life	of	these	and	other	transgenic	mice.	This	160 correlation	in	Αβ	mice	contrasts	with	the	interaction	of	microglia	and	neurofibrillary	161 tangles	in	mice	with	Tau	mutations,	in	which	microglial	genes	are	only	upregulated	with	162 advanced	tangle	load	(www.mouseac.org).[10]	163 	164 Here	we	extend	our	previous	studies	on	TASTPM	mice	to	understand	the	relationship	165 between	early	changes	in	synaptic	transmission,	synaptic	plasticity,	cognitive	function	166 and	microglia.	We	study	the	development	of	plaques	in	more	detail	and	dissect	out	the	167 microglial	response	to	distinguish	between	the	numbers	of	microglia	and	their	168 phagocytic	status.	We	find	that,	like	synaptic	changes,	microglia	are	more	prevalent	even	169 before	plaques	are	detectable,	whereas	their	phagocytic	phenotype	is	age-related,	170 coming	much	later.	We	then	proceed	to	study	hippocampal	synaptic	plasticity	and	171 hippocampus-dependent	learning,	in	the	forced-alternation	T-maze,	enabling	172 identification	of	Aβ	phenotypes,	finding	little	cognitive	deficit	even	with	a	heavy	plaque	173 load	but	clear	behavioural	changes,	probably	related	to	increased	levels	of	anxiety.	174 While	we	continue	to	focus	mainly	on	the	previously	defined	TASTPM	mice	(double	175 hemizygote),	we	have	broadened	the	study	to	investigate	dose	dependency	of	the	176 transgene	by	including	mice	homozygous	for	both	genes.	The	effect	of	the	individual	177 genes	is	also	investigated	in	mice	with	hemizygous	expression	of	only	one	or	the	other	178 gene.	When	not	otherwise	defined,	TASTPM	mice	hence	refers	to	the	double	hemizygous	179 mouse.	 	180 
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Methods	181 
Animals	182 All	experiments	were	performed	in	agreement	with	the	UK	Animals	(Scientific	183 Procedures)	Act	1986,	with	local	ethical	approval	and	in	agreement	with	the	184 GlaxoSmithKline	statement	on	use	of	animals.	Male	TASTPM	mice	and	C57Bl/6j	mice	185 were	supplied	by	GlaxoSmithKline	and	bred	either	at	Charles	River	Laboratories	186 International,	Inc.	(Margate,	UK)	or	at	UCL	by	crossing	male	homozygous	TASTPM	with	187 female	C57Bl/6j.	Age-matched,	non-littermate	male	C57Bl/6j	mice	were	used	as	wild	188 type	controls.		In	some	experiments,	double	homozygous	TASTPM	were	bred.	Single	189 mutant	TAS	(APPSwe)[17]	or	TPM	(PSEN1M146V)[15]	mice	were	bred	by	crossing	190 hemizygous	parents.	Mice	from	Charles	River	were	shipped	to	UCL	upon	weaning	at	21-191 days-old.	192 	193 In	this	study	we	avoided	single	housing	by	keeping	mice	in	large	open	cages	(20	x	35	x	194 45	cm)	and	enriching	their	environments.	Under	these	conditions,	while	the	aggressive	195 nature	of	the	TASTPM	mouse	is	not	completely	avoided,	it	is	less	of	a	problem	and	196 allows	group	housing	to	be	maintained	over	the	lifetime	of	the	mice.	Thus,	cages	197 containing	2-8	male	mice	were	maintained	in	a	12-hour	light/12-hour	dark	cycle	with	198 food	(Envigo	2018	Teklad	global	18%	protein	rodent	diet)	and	water	ad	libitum.	199 Environmental	enrichment	consisted	of	changes	of	food	location,	bedding	type	(e.g.	200 tissue,	shredded	paper,	paper	roll,	paper	bags)	and	inanimate	objects	(e.g.	running	201 wheels,	rodent	balls,	tubing,	houses	(mostly	purchased	from	Eli	Lilly	Holdings	Limited,	202 Basingstoke,	UK))	within	the	cage	at	least	once	per	week.	Mice	were	used	for	203 experimentation	at	the	ages	stated	(±	0·5	months)	and,	where	unavoidable,	were	single-204 housed	for	no	longer	than	24	hours.	Tails	or	ear	punches	were	used	for	genotyping	by	205 standard	PCR	protocols	to	ensure	the	presence	of	the	expected	genes.	206 
	207 
Genotyping	208 
Genotype	confirmation	using	conventional	PCR	methods	209 Briefly,	genomic	DNA	was	extracted	using	the	‘HotSHOT’	lysis	method.	Alkaline	lysis	210 reagent	(25	mM	NaOH,	0·2	mM	EDTA,	pH12)	was	added	to	tissue	samples	prior	to	211 heating	to	95°C	for	30	minutes.	The	sample	was	then	cooled	to	4°C	before	the	addition	of	212 
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neutralisation	buffer	(40	mM	Tris-HCl,	pH	5).	The	PCR	reaction	was	performed	through	213 addition	of	MyTaq	DNA	Polymerase	(Bioline)	reaction	buffer	and	primer	pairs:	214 	215 TAS	(APPSwe):	216 5'	GAATTGACAAGTTCCGAGGG	3'	217 5'	GGGTACTGGCTGCTGTTGTAG	3'	218 	219 TPM	(PSEN1M146V):	220 5'	GTTACCTGCACCGTTGTCCT	3'	221 5'	GCTCCTGCCGTTCTCTATTG	3'	222 	223 using	the	cycling	parameters:	94°C	(30	s),	58°C	(30	s),	72°C	(30	s),	for	30	cycles	and	a	224 final	extension	at	72°C	for	4	min.	PCR	product	sizes	366	bp	for	TAS	and	104	bp	for	TPM.	225 
	226 
Immunohistochemistry	227 Animals	were	deeply	anaesthetised	(1:10	Euthatal:Intra-Epicaine,	National	Veterinary	228 Supplies)	and	transcardially	perfused	with	0·1	M	phosphate	buffer	saline	(PBS)	followed	229 by	10%	buffered	formal	saline	(Pioneer	Research	Chemicals	Ltd).	Alternatively,	single	230 hemispheres	were	drop-fixed	immediately	following	brain	extraction	for	231 electrophysiology.	The	brains	were	post-fixed	in	10%	buffered	formal	saline	for	24hrs	232 and	cryoprotected	in	30%	sucrose/0·03%	sodium	azide/PBS	at	4°C	for	at	least	24hrs	233 before	sectioning	or	storage.	Transverse	sections	were	cut	at	30	μm	through	the	full	left	234 hippocampus	using	a	frozen	sledge	microtome	(SM	2000	R,	Leica)	and	collected	into	a	235 24-well	plate	containing	PBS/sodium	azide	(0·03%)	for	storage	at	4°C.	Serial	sections	236 were	placed	in	separate	wells	until	all	wells	contained	a	section	and	collection	then	237 continued	serially	from	Well	1	so	that	within	each	well	the	transverse	sections	were	238 from	the	length	of	the	hippocampus	at	least	720µm	apart.	239 	240 Standard	immunohistochemical	techniques	were	employed.	For	Aβ	staining	only,	241 antigen	retrieval	was	achieved	by	submerging	sections	in	10	mM	sodium	citrate	(pH	6·0)	242 in	0·05%	Triton	X-100	and	heated	in	a	water	bath	at	80°C	for	30	minutes.	Sections	for	all	243 immunohistochistry	were	then	washed	in	PBS,	followed	by	0·3%	Triton	X-100	in	PBS	244 and	subsequent	blocking	in	8%	horse	serum/Triton/PBS	for	1	hour.	Incubation	with	245 
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primary	antibody	(table	1)	in	blocking	solution	was	performed	overnight	at	4°C.	246 Sections	were	again	washed	with	Triton/PBS.	The	appropriate	Alexa-conjugated	247 secondary	antibody	(1:500;	Invitrogen)	was	added	to	blocking	solution	for	a	2-hour	248 incubation	at	room	temperature	in	the	dark.	Following	PBS	wash,	DAPI	(1:10,000)	was	249 applied	to	all	sections	for	5	minutes.	Sections	were	washed	for	a	final	time	in	PBS	before	250 mounting.	Age-matched	sections	from	wild	type	controls	were	stained	in	parallel	for	all	251 ages.	Sections	were	mounted	in	anatomical	order	onto	SuperFrost	Plus	glass	slides	by	252 floating	on	PBS	and	then	cover-slipped	using	Fluoromount	G	mounting	medium.	253 	254 
Imaging	and	data	analysis	255 Sections	were	imaged	for	quantification	using	an	EVOS	FL	Auto	Cell	Imaging	System	256 (Life	technologies).	Tiled	images	were	taken	of	the	whole	transverse	hippocampal	257 section	using	a	20X	objective.	To	determine	cell	densities,	an	area	of	400	μm	x	240	μm	258 was	defined	in	the	CA1,	CA3	and	the	inner	blade	of	the	dentate	gyrus.	Cell	counts	were	259 performed	using	Adobe	Photoshop	CS6.	A	minimum	of	three	sections	were	used	to	260 create	a	mean	for	each	animal.	Sections	for	any	given	condition	were	obtained	from	the	261 same	collection	well	within	the	24-well	plate	and	were	therefore	a	minimum	of	720	μm	262 apart,	thus	avoiding	multiple	counts	of	the	same	cells.	Counts	of	objects	touching	the	263 boundaries	of	the	area	of	interests	were	only	included	from	the	north	and	east	borders	264 and	excluded	from	the	south	and	west	borders.	265 
	266 
Electrophysiological	recordings	267 
Acute	hippocampal	brain	slice	preparation	268 Mice	were	decapitated	and	the	brain	rapidly	removed	and	placed	in	ice-cold	dissection	269 artificial	cerebrospinal	fluid	(ACSF,	containing	(in	mM):	125	NaCl,	2·4	KCl,	26	NaHCO3,	270 1·4	NaH2PO4,	20	D-glucose,	3	MgCl2,	0.5	CaCl2,	pH	7·4,	~315	mOsm/l).	After	271 approximately	two	minutes	in	ice-cold	dissection	ACSF,	the	brain	was	prepared	for	272 slicing	by	removing	the	cerebellum,	hemisection	of	the	forebrain	and	a	segment	cut	273 away	from	the	dorsal	aspect	of	each	hemisphere	at	an	angle	of	approximately	110°	from	274 the	midline	surface	to	optimise	slicing	transverse	to	the	hippocampus.	Each	hemisphere	275 was	then	glued	with	cyanoacrylate	(Loctite	406,	Henkel	Loctite	Limited,	UK)	on	this	276 surface	onto	the	stage	of	a	vibrating	microtome	(Integraslice	model	7550	MM,	Campden	277 Instruments,	Loughborough,	UK)	containing	frozen	dissection	ACSF	and	400	μm	278 
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transverse	slices	of	hippocampus	cut.	As	each	slice	of	a	hemisphere	was	cut,	the	279 hippocampus	was	dissected	out,	retaining	a	portion	of	entorhinal	cortex	and	the	280 resulting	smaller	slice	was	placed	into	a	chamber	containing	‘Carbogenated’	(95%	281 O2/5%	CO2;	BOC	Limited)	dissection	ACSF	at	room	temperature	(approximately	21°C).	282 After	5	minutes,	slices	were	then	transferred	into	a	fresh	chamber	held	at	36°C	with	the	283 same	dissection	ACSF.	At	5-minute	intervals,	they	were	then	consecutively	transferred	284 to	physiological	Ca2+	and	Mg2+	ion	concentrations	(in	mM):	i)	1	Mg2+,	0.5	Ca2+;	ii)	1	Mg2+,	285 1	Ca2+;	iii)	1Mg2+,	2	Ca2+.	After	approximately	20	minutes	at	35°C	(i.e.,	once	transferred	286 into	the	1	Mg2+,	2	Ca2+	ACSF).	287 
	288 
Patch-clamp	recordings	in	brain	slices	289 Once	transferred	to	1	Mg2+,	2	Ca2+	ACSF,		slices	were	allowed	to	return	to	room	290 temperature	and	after	at	least	a	further	40	minutes	recovery	time,	a	single	slice	was	291 transferred	to	a	submerged	chamber	and	superfused	with	recording	ACSF	(containing	292 (in	mM):	125	NaCl,	2·4	KCl,	26	NaHCO3,	1·4	NaH2PO4,	20	D-glucose,	1	MgCl2,	2	CaCl2,	293 bubbled	with	Carbogen).	Individual	CA1	pyramidal	or	dentate	gyrus	granule	neurones	294 were	visualised	using	infrared-differential	interference	contrast	microscopy	on	an	295 upright	microscope	(model	BX50WI,	Olympus,	UK).	Glass	microelectrodes	for	patch-296 clamp	were	pulled	from	borosilicate	glass	capillaries	(Catalogue	number	GC150F-7.5,	297 1·5	mm	OD	x	0·86	mm	ID,	Biochrom-Harvard	Apparatus	Ltd,	Cambridge,	UK)	on	a	298 vertical	puller	(model	PP830,	Narishige	International	Ltd,	London	UK).	Electrodes	(tip	299 resistance	approximately	5	MW)	were	filled	with	a	CsCl-based	internal	solution	300 (containing	(in	mM):		CsCl	140,	HEPES	5,	EGTA	10,	Mg-ATP	2,	pH	7·4,	~290	mOsm/l).	301 Patch-clamp	recordings	were	performed	using	an	Axopatch	1D	(Molecular	Devices,	302 Sunyvale,	CA,	USA),	and	current	signals	low-pass	filtered	at	10	kHz	then	2	kHz	303 (Brownlee	Precision	Model	440,	NeuroPhase,	Santa	Clara,	CA,	USA)	during	digitization	304 (10	kHz;	1401plus,	Cambridge	Electronic	Design,	Limited,	Cambridge,	UK)	and	acquired	305 using	WinWCP	(for	isolated	events;	version	4.6.1;	John	Dempster,	Strathclyde	306 University,	UK)	and	WinEDR	(for	continuous	recordings;	John	Dempster,	Strathclyde	307 University,	UK).	Stimulation	was	applied	via	a	patch	electrode	filled	with	ACSF,	placed	308 extracellularly	in	the	appropriate	axon	path	using	a	square	pulse	constant-voltage	309 stimulator	(100	µs;	DS2A-MkII,	Digitimer	Ltd,	UK)	triggered	by	WinWCP.	310 	311 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/420349doi: bioRxiv preprint first posted online Sep. 17, 2018; 
Medawar et al 2018 - Revision  
Page 11 of 46 
WinEDR	synaptic	analysis	software	was	used	for	detection	of	spontaneous	and	312 miniature	currents	and	WinWCP	used	to	analyse	identified	spontaneous,	miniature	and	313 evoked	currents.	Criteria	for	detection	of	spontaneous	or	miniature	currents	was	to	314 remain	over	a	threshold	of	3	pA	for	2	ms.	Currents	were	inspected	by	eye	and	only	315 included	if	the	rise	time	was	<3	ms	and	faster	than	the	decay.	316 
	317 
Field	potential	recordings	in	brain	slices	318 Slices	were	transferred	as	needed	to	a	heated	(30±1°C)	submerged	chamber	and	319 superfused	with	ACSF	and	allowed	to	recover	for	1	h	in	the	recording	chamber.	A	glass	320 stimulating	electrode	(filled	with	ACSF,	resistance	~2	MΩ)	and	an	identical	recording	321 electrode	(connected	to	an	AxoClamp	1B	via	a	1X	gain	headstage)	were	both	positioned	322 in	stratum	radiatum	of	the	CA1	field	to	obtain	a	dendritic	excitatory	postsynaptic	field	323 potential	(fEPSP).	Recordings	were	controlled	and	recorded	using	WinWCP	software	(as	324 above),	filtered	at	10	kHz	and	subsequently	at	3	kHz	and	digitized	at	10	kHz	via	a	325 micro1401	interface	(Cambridge	Electrical	Designs,	UK).	Stimuli	(constant	voltage	10-326 70V,	100	μs;	model	Digitimer	DS2A-MkII	or	Grass	SD9)	were	applied	at	0·1	Hz	and	327 resultant	fEPSPs	subsequently	averaged	over	consecutive	1-minute	intervals.	328 Stimulation	intensity	was	set	at	approximately	30-50%	of	the	intensity	required	to	329 evoke	a	population	spike	or	the	maximum	fEPSP	amplitude	obtained	and	a	≥15-minute	330 stable	baseline	recorded.	LTP	conditioning	was	applied	at	test-pulse	stimulus	intensity	331 and	consisted	of	either	3	trains	of	tetani,	each	consisting	of	20	pulses	at	100	Hz,	1·5	s	332 inter-train	interval	or	4	trains	of	theta-burst	stimuli	(TBS),	each	train	consisting	of	4	333 pulses	at	100	Hz	repeated	8	times	at	20	Hz;	inter-train	interval	1	minute.	Following	334 conditioning,	fEPSPs	were	evoked	at	0·1	Hz	for	1	hour.	335 	336 
Behavioural	testing	337 
T-maze	forced	alternation	task		338 Previously	reported	methods,	optimised	for	mouse,	were	used	to	assess	hippocampus-339 dependent	learning	[18].	Mice	were	food	deprived	to	90%	free-feeding-weight,	beginning	340 2	days	before	the	start	of	the	habituation	phase	and	with	ad	libitum	access	to	water.	341 Each	mouse	was	handled	at	the	start	of	food	deprivation	and	throughout	T-maze	342 habituation	for	15-20	minutes	per	weekday.	343 	344 
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The	T-maze	was	constructed	from	three	arms,	each	measuring	50	x	8	cm	with	10	cm	345 colourless	Perspex	walls	and	a	grey	floor,	mounted	on	a	table	in	the	centre	of	a	room	346 with	numerous	distal	visual	cues,	such	as	black	and	white	posters	on	the	walls.	Black	347 barriers	were	used	to	block	the	start	and	goal	arms.	Reward	consisted	of	a	drop	of	Nestlé	348 CarnationÔ	condensed	milk	that	was	placed	at	the	end	of	each	goal	arm.	Arms	were	349 cleaned	with	70%	ethanol	between	all	runs	to	reduce	odour	cues.	In	addition,	in	an	350 inaccessible	well	a	drop	of	reward	is	always	present	in	both	arms.	351 	352 Mice	received	4	days	of	habituation	to	the	maze,	during	which	time	they	were	allowed	to	353 explore	the	maze	for	5	minutes	with	all	arms	open.	During	the	first	two	days	of	354 habituation,	reward	was	scattered	along	the	floor	and	in	food	wells	to	encourage	355 exploratory	behaviour;	then	restricted	to	only	the	food	wells	at	the	ends	of	the	goal	arms	356 in	the	last	two	days.	357 	358 The	behavioural	regime	lasted	for	three	weeks,	with	five	days	of	training	per	week.	Each	359 day,	animals	received	six	trials;	each	trial	consisted	of	a	sample	and	choice	run.	In	the	360 sample	run,	one	arm	was	blocked	off.	The	mouse	was	placed	at	the	starting	point	at	the	361 base	of	the	T,	the	barrier	was	removed	and	the	mouse	was	allowed	to	go	to	the	available	362 arm	and	given	20	s	to	eat	a	drop	of	reward	from	the	food	well.	For	the	choice	run,	the	363 mouse	was	immediately	returned	to	the	starting	point	and	the	barrier	in	the	previously	364 blocked	arm	removed.	The	starting	barrier	was	then	raised	and	the	animal	allowed	to	365 choose	between	the	two	arms	but	only	rewarded	if	it	chose	the	previously	unvisited	366 arm.	Thus,	a	correct	choice	was	scored	when	the	mouse	selected	the	arm	not	visited	in	367 the	sample	run.	After	the	choice	run,	the	mouse	was	removed	from	the	maze	and	placed	368 in	its	holding	box.	The	location	of	the	sample	arm	(left	or	right)	was	varied	369 pseudorandomly	across	the	session	and	mice	received	three	left	and	three	right	370 presentations,	with	no	more	than	two	consecutive	trials	with	the	same	sample	location.	371 Animals	were	allowed	a	maximum	of	5	minutes	to	make	a	choice	to	enter	a	goal	arm	in	372 both	runs	before	a	trial	was	aborted.	If	an	incorrect	arm	was	chosen	during	the	choice	373 run,	the	mouse	was	confined	in	the	arm	with	no	reward	for	20	s	and	then	removed	from	374 the	maze.	375 	376 
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During	the	first	two	weeks	of	training	the	choice	run	followed	immediately	after	the	377 sample	(test)	run	(there	was	a	delay	of	approximately	15	s	between	runs	for	cleaning	378 and	resetting	the	maze).	Data	was	analysed	in	blocks	of	2	days	and	hence	blocks	1-5	379 represent	the	first	2	weeks	of	training.	380 	381 On	the	first	day	of	the	third	week,	mice	received	a	repeat	of	the	previous	training	382 sessions	in	order	to	assess	retention	of	the	task	(block	6).	On	the	following	four	days,	383 longer	delays	(2-10	minutes)	were	introduced	between	the	sample	and	choice	runs	to	384 extend	the	time	that	the	previous	choice	was	to	be	held	in	memory	(blocks	7	and	8	in	385 response	times).	During	these	intervals,	each	animal	was	placed	in	a	separate	holding	386 box.	Each	mouse	received	two	of	each	of	the	delay	periods	per	day,	varied	387 pseudorandomly	both	within	and	across	days.	Response	times	were	calculated	from	the	388 time	that	the	starting	block	was	removed	until	the	mouse	made	a	choice	of	arms	and	all	389 four	paws	had	crossed	the	entry	point.	Squads	of	15-17	mice	were	run	per	day.	During	390 training	data	are	presented	as	blocks	averaged	across	2	days	for	each	animal	and	391 expressed	as	mean	±	SEM.	For	delays	the	four	runs	for	each	delay	are	averaged.	392 
	393 
Elevated	plus	maze	394 The	plus-maze	was	constructed	from	two	enclosed	arms	(30	cm	x	5	cm	x	20	cm)	and	two	395 open	arms	(30	cm	x	5	cm	x	0.8	cm)	connected	by	a	small	central	platform	(5	x	6	cm);	the	396 two	closed	and	two	open	arms	were	positioned	opposite	each	other,	respectively.	The	397 maze	was	elevated	30	cm	above	a	table.	398 	399 Mice	were	placed	in	the	centre	of	the	plus	maze	facing	an	open	arm	and	allowed	to	freely	400 explore	the	maze	for	one	6-minute	trial.	The	time	spent	on	each	arm	(open	versus	401 closed)	was	recorded,	as	well	as	the	number	of	entries	into	the	arms.	An	entry	into	an	402 arm	was	defined	as	all	four	paws	resting	on	a	given	arm.	403 
	404 
Open	field	405 The	open	field	consisted	of	a	plastic	cylinder	(diameter:	47·5	cm,	height	36	cm)	with	a	406 white	plastic	floor.	Mice	were	placed	on	the	periphery	of	the	open	field	floor	and	allowed	407 to	explore	freely	for	30	minutes.	The	path	of	each	mouse	was	recorded	using	dacQUSB	408 recording	system	(Axona,	St.	Albans,	U.K)	at	a	sample	rate	of	50	Hz.	The	open	field	was	409 
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optically	divided	into	a	central	circle	and	a	peripheral	ring,	each	with	equal	area.	The	410 path	of	the	mouse	was	analysed	offline	using	ImageProPlus.	Path	length	and	dwell	times	411 in	the	periphery	and	centre	were	calculated	using	custom	made	routines	written	in	412 Matlab	R2010a	(MathWorks).	413 	414 
Light/dark	box	415 The	dark	box[19]	measured	20	cm	x	20	cm	x	30	cm,	with	black	walls,	floor	and	lid.	The	416 light	box	measured	30	cm	x	30	cm	x	30	cm	with	a	white	floor	and	light	grey	walls.	The	417 boxes	were	connected	by	an	opening	in	the	partition	between	the	two	compartments.	An	418 overhead	light	provided	bright	illumination	in	the	light	box.	Mice	were	placed	in	the	419 centre	of	the	light	compartment	facing	away	from	the	opening	and	then	allowed	to	420 explore	for	a	period	of	6	minutes.	Time	spent	in	each	box	and	the	number	of	entries	into	421 each	box	were	recorded.	An	entry	into	a	box	was	defined	as	all	four	paws	resting	inside	422 the	given	box.	423 	424 
Statistics	425 All	data	analysis	was	carried	out	blind	to	genotype.	All	statistics	were	performed	using	426 Graphpad	Prism	6	with	appropriately	designed	two-tailed	t-test	or	ANOVA.	Post	hoc	427 tests	were	only	performed	if	a	significant	interaction	between	the	independent	variables	428 was	obtained.	Animals	were	considered	as	independent	samples	and,	where	multiple	429 data	were	collected	from	an	animal,	these	were	averaged	(mean)	prior	to	pooling.	Thus	430 sample	sizes	represent	the	number	of	animals.	Unless	stated	otherwise,	data	are	431 presented	as	mean	±	SEM	and	differences	considered	significant	at	p<0·05.	 	432 
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Results	433 
Plaque	development	in	hippocampus	434 In	TASTPM	mice	of	different	ages,	individual	plaques	were	counted	in	the	hippocampus	435 and	their	sizes	measured	to	assess	whether	the	distribution	changed	over	time	(Fig	1).	436 Initially,	at	3-4	months	of	age,	only	small	plaques	could	be	detected	(<100	µm2)	and	437 these	were	very	sparse	(Fig.	1a-c).	However,	the	number	of	small	plaques	increased	438 exponentially,	initially	approximately	doubling	every	month,	and	continuing	to	increase	439 at	a	slower	rate	until	14	months	of	age	(Fig.	1b).	Hence,	at	least	up	until	this	age,	new	440 plaques	were	being	seeded.	By	7	months	plaques	up	to	200	µm2	were	consistently	seen	441 but	were	similar	in	frequency	to	the	smallest	plaques	at	3-4	months,	presumably	442 representing	the	growth	of	the	earliest	seeds.	Plaques	of	>500	µm2		were	only	443 consistently	detected	at	ages	over	10	months	but,	from	this	age	on,	a	wide	range	of	444 plaques	sizes	were	evident,	with	occasional	plaques	of	over	2500	µm2	detected.	445 Interestingly,	between	14	and	15	months	of	age,	very	little	change	in	the	number	of	446 plaques	was	detected	but	the	largest	plaques	continued	to	grow.	As	individual	plaques	447 were	not	tracked	over	time,	we	cannot	be	entirely	sure	that	the	progression	up	to	14	448 months	is	due	to	continuous	seeding	of	small	plaques	that	gradually	grow	with	ongoing	449 plaque	deposition;	however,	this	seems	the	most	likely	explanation.	The	fact	that	the	450 rate	of	addition	of	small	plaques	decreases	gradually	until	it	plateaus	around	14	months	451 of	age	suggests	that,	as	the	plaques	get	denser,	some	of	the	small	plaques	start	to	fuse	452 with	larger	plaques.	In	some	cases,	large	plaques	were	present	that	possessed	a	halo	of	453 Aβ	around	the	dense	core,	with	dense	puncta	of	Aβ	visible	within	the	halo,	possibly	454 representing	more	recently	seeded	plaques	being	engulfed	as	the	large	plaque	grows	455 (Fig	1a).	456 	457 When	the	gene-dose	was	doubled	by	using	double	homozygous	TASTPM	mice,	plaques	458 were	first	detected	at	about	2	months	of	age	(Fig	1e).		Similarly	to	the	hemizygous	mice,	459 plaque	density	and	size	increased	with	age	but	perhaps	surprisingly,	did	not	reach	a	460 greater	density	than	that	observed	in	the	hemizygotes.	461 	462 Mice	carrying	only	the	single	mutations	were	also	examined.	In	TAS	mice	(APPSwe),	small	463 plaques	were	detected	at	16	months.	While	plaque	density	and	size	increased	with	age,	464 plaque	loads	did	not	reach	that	seen	in	the	double	mutant	TASTPM	mice,	even	at	the	465 
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very	advanced	age	of	27	months.	In	TPM	mice	(PSEN1M146V),	there	were	no	plaques	466 observed	at	any	age.	467 	468 
Microglia	469 Having	previously	observed	that	a	module	of	microglial	genes	increased	in	expression	in	470 Αβ	mice	(including	TASTPM)	in	close	correlation	with	plaque	load[10],	we	went	on	to	471 examine	the	densities	of	total	and	CD68	positive	of	microglia	in	more	detail	in	these	472 mice	(Fig	2).	There	was	an	increased	density	of	microglia	(assessed	by	Iba1	positive	473 cells)	in	CA1	at	very	early	ages,	with	increases	(approximately	double)	compared	to	wild	474 type	already	evident	by	2	months	of	age,	even	before	plaques	could	be	detected	(Fig	475 2a&c;	2-8	months,	n=6-12,	two-way	ANOVA,	p<0·01).	However,	note	that	Aβ	levels	are	476 already	raised	by	2	months[16]	and	it	is	possible	that	small	plaque	seeds	(<	the	10	µm2	477 threshold)	may	already	be	depositing	at	this	time.	There	was	also	an	age-dependent	478 increase	in	Iba1	positive	microglia	in	both	wild	type	and	TASTPM	mice	at	around	10	479 months	of	age.	480 	481 In	contrast	to	total	microglia,	the	microglial	phagocytic	phenotype,	as	measured	by	CD68	482 labelling,	was	very	low	in	all	young	animals	and	only	increased	from	around	10-12	483 months.	Again,	this	happened	in	both	wild	type	and	TASTPM	mice.	The	percentage	of	484 phagocytic	microglia	tended	to	be	slightly	higher	in	TASTPM	mice	as	compared	to	wild	485 type	(14-20	months,	n=5-9,	two-way	ANOVA	p=0·07).	This	coincided	with	the	486 appearance	of	large	plaques	(Fig	1c&d).	Interestingly,	the	number	of	microglia	and	their	487 CD68	status	seem	to	plateau	at	this	stage,	with	no	further	increase	in	density	beyond	12	488 months	of	age.	489 	490 When	the	double	homozygous	TASTPM	mice	were	examined,	a	very	similar	pattern	was	491 observed	for	densities	of	both	total	microglia	and	CD68	positive	microglia	(Fig	2d).	As	492 expected	both	plaque	load	and	microglial	response	was	greater	in	the	homozygous	mice.	493 	494 Sections	from	single	mutant	mice	were	also	stained	for	both	IBA1	and	CD68.	The	APPSwe	495 TAS	mice,	which	develop	plaques	from	around	16	months	(Fig	1f),	had	a	higher	total	and	496 CD68	positive	microglia	at	both	18	and	27	months	of	age	(main	effects	of	genotype	for	497 both	Iba1	and	CD68	in	separate	two-way	ANOVAs;	p<0.05).	In	contrast,	the	PSEN1M146V	498 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/420349doi: bioRxiv preprint first posted online Sep. 17, 2018; 
Medawar et al 2018 - Revision  
Page 17 of 46 
TPM	mice,	which	do	not	develop	plaques	at	any	age,	showed	no	difference	from	wild	499 type	mice	in	their	microglial	phenotype	at	4	months	of	age	for	either	total	or	CD68	500 positive	microglia	(Fig	2g,	two-tailed	t-test,	p>0.5).	501 	502 Very	similar	changes	in	total	microglial	and	CD68	positive	microglial	densities	were	503 found	in	dentate	gyrus,	CA3	and	subiculum	(data	not	shown).	504 
	505 
Synaptic	currents	in	CA1	neurones	506 Spontaneous	excitatory	activity	507 When	spontaneous	excitatory	currents	are	recorded	from	CA1	pyramidal	neurones	in	508 the	presence	of	a	GABAA	receptor	antagonist	(gabazine,	6	µM),	the	substantial	loss	of	509 spontaneous	activity	we	have	previously	reported	up	to	4	months	of	age[16]	is	largely	510 maintained	through	to	18	months	(Fig	3a).	At	8	months	there	was	almost	a	complete	511 loss	of	action	potential-dependent	spontaneous	activity	in	the	transgenic	mice	(Fig	3aii),	512 with	the	frequency	almost	exactly	the	same	as	that	of	miniature	currents	(Fig	3aiii)	513 observed	in	the	presence	of	1	μM	tetrodotoxin.	This	result	was	almost	identical	to	what	514 we	have	previously	reported	at	4	months.	By	12-18	months,	a	decrement	in	frequency	of	515 miniature	EPSCs	had	also	developed	but	the	action	potential	mediated	spontaneous	516 excitatory	current	frequency,	although	significantly	lower	in	transgenic	mice	than	wild	517 type	mice,	were	at	a	higher	frequency	than	the	miniature	currents	in	the	same	genotype,	518 implying	that	some	spontaneous	action	potential-mediated	activity	was	occurring	in	the	519 transgenic	mice	at	these	older	ages	(Fig	3a).	There	were	no	differences	between	520 genotypes	of	mEPSC	amplitudes	or	decay	time	constants	(data	not	shown).	521 	522 When	excitatory	activity	was	evoked	by	stimulating	the	Schaffer	collaterals	in	slices	523 from	older	animals,	the	previously	reported	increase	in	release	probability	at	4	months,	524 as	assessed	by	a	lower	paired-pulse	facilitation	and	confirmed	by	a	reduction	in	failure	525 to	release	glutamate	in	response	to	minimal	stimulation[16],	was	maintained.	Thus,	at	12	526 months	of	age,	paired-pulse	ratio	was	lower	in	TASTPM	than	wild	type	mice	at	both	25	527 and	50	ms	inter-stimulus	intervals	(n=5-8,	two-way	ANOVA,	main	effect	of	genotype	528 p<0·02),	while	at	18	months	of	age,	the	lower	paired-pulse	ratio	was	only	evident	at	25	529 ms,	resulting	in	a	genotype	x	interval	interaction	(p<0·05)	and	a	highly	significant	Sidak	530 post	hoc	pairwise	comparison	between	genotype	at	25	ms	(p<0·005).	531 
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	532 Inhibitory	activity	is	unchanged	533 Although	we	have	concentrated	our	detailed	analysis	on	glutamatergic	activity,	we	were	534 able	to	gain	an	overview	of	inhibitory	activity	from	the	spontaneous	activity	recorded	in	535 the	absence	of	antagonists	by	utilising	CsCl	as	the	internal	patch	pipette	solution.	Hence,	536 in	the	experiments	examining	pharmacologically	isolated	EPSCs	above,	initially	537 spontaneous	currents	were	recorded	in	the	absence	of	receptor	antagonists.	When	the	538 GABAA	receptor	antagonist	was	included	in	the	perfusion	solution,	the	frequency	of	539 currents	was	decreased	to	about	5-10%	in	wild	type	slices.	Consequently,	GABAA	540 receptor-mediated	activity	contributes	about	90%	of	the	frequency	of	the	initial	541 recording	of	mixed	spontaneous	activity.	Note	that,	if	the	recording	were	made	in	the	542 presence	of	a	glutamatergic	antagonist,	any	currents	that	were	due	to	spontaneous	543 glutamatergic	activity	mediating	feed-forward	or	feed-back	inhibition	would	be	lost.	544 Hence,	the	assessment	of	the	drug-free	frequency	is	a	better	assessment	of	the	545 contribution	of	inhibition	with	the	understanding	that	this	will	overestimate	frequency	546 by	about	10%.	Under	these	conditions	we	find	that	there	is	no	significant	change	in	547 inhibitory	synaptic	activity	in	TASTPM	mice	at	any	age	from	4	to	18	months	(Fig	548 	3c).	Note	that,	considering	the	very	substantial	change	in	spontaneous	glutamatergic	549 activity,	this	implies	that	very	little	of	the	GABAergic	activity	is	dependent	on	550 glutamatergic	input.	551 
	552 Synaptic	plasticity	is	altered	in	TASTPM	mice	553 Considering	the	changes	in	excitatory	transmission	it	seemed	likely	that	synaptic	554 plasticity,	in	particular,	long-term	potentiation	(LTP),	the	best	cellular	model	we	have	555 for	the	laying	down	and	retrieval	of	memory[20],	could	be	altered.	To	assess	effects	on	556 LTP,	field	potentials	were	recorded	from	CA3-CA1	synapses	in	acute	brain	slices	557 prepared	from	TASTPM	mice	at	ages	preceding	detectable	Αβ	plaques	(2	months)	558 through	to	ages	with	a	heavy	plaque	load	(12-18	months).	559 	560 Field	input-output	relationship	was	not	significantly	changed	at	any	of	the	ages	tested	561 (Fig	4a).	Moreover,	unlike	our	previously	reported	result	using	patch	clamp	recording	in	562 the	presence	of	a	GABAA	receptor	antagonist[16],	in	field	recordings	with	the	inhibitory	563 network	intact,	paired-pulse	ratios	were	not	significantly	changed	between	genotypes	at	564 
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any	of	the	ages	tested	(Fig	4b).	This	suggests	that	the	observed	changes	in	paired-pulse	565 ratio	were	masked	when	GABAergic	activity	was	not	blocked,	presumably,	at	least	in	566 part,	by	feed-forward	inhibition	decreasing	release	on	the	second	stimulus.	567 	568 At	2	months	of	age,	LTP	is	altered	in	TASTPM	mice	but	this	is	dependent	on	the	569 induction	protocol.	When	LTP	was	induced	by	tetanic	stimulation	in	these	young	mice,	570 the	magnitude	of	LTP	was	greater	in	slices	from	TASTPM	than	from	wild	type	mice.	571 Paired-pulse	ratios	remained	unaltered	when	the	last	ten	minutes	of	the	post-induction	572 recordings	was	compared	to	the	baseline	in	both	genotypes	(Fig	4c&d).	This	suggested	573 that	the	change	in	amplitude	seen	in	LTP	was	due	to	a	postsynaptic	change.	In	contrast,	574 when	LTP	was	induced	using	TBS,	there	was	no	difference	between	the	wild	type	and	575 transgenic	mice	(Fig	4e).	Surprisingly,	however,	despite	LTP	remaining	unchanged	after	576 theta	burst	stimulation,	the	paired-pulse	ratio	decreased	significantly	between	the	pre-577 induction	baseline	and	the	last	10	minutes	of	LTP	in	the	TASTPM	but	not	in	the	wild	type	578 mice.	This	suggests	that	the	locus	of	expression	of	this	form	of	LTP	is	likely	to	have	a	579 presynaptic	component	in	transgenic	mice	at	this	age.	Note	that,	considering	an	increase	580 in	release	probability	would	be	expected	to	enhance	the	postsynaptic	response,	this	581 would	suggest	that	the	postsynaptic	contribution	to	LTP	could	be	decreased	in	the	582 transgenic	mice	possibly	with	one	locus	of	change	compensating	for	the	other.	583 	584 At	4	months	of	age,	the	effects	of	the	different	stimulus	protocols	had	changed.	By	this	585 age,	a	clear	deficit	was	seen	in	LTP	induced	by	tetanic	stimulation,	which	was	the	586 reverse	change	to	that	seen	at	2	months.	Moreover,	similar	effects	were	seen	in	two	587 separate	cohorts	of	4-month-old	mice	(cohort	1	shown	in	Fig	4c;	pooled	data	shown	in	588 Fig	4d.	589 	590 TBS-induced	LTP	(Fig	4e)	was,	like	at	2	months,	of	similar	magnitude	between	591 genotypes	but	analysis	of	paired-pulse	ratios,	following	LTP	induction,	indicated	that	592 LTP	has	a	similar	locus	of	expression	in	the	two	genotypes.	593 	594 In	addition,	chemically-induced	LTP	was	also	examined	in	a	separate	set	of	slices,	using	595 transient	application	of	the	potassium	channel	blocker	tetraethylammonium,	applied	596 after	completion	of	a	tetanus-induced	LTP	experiment.	As	expected,	597 
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tetraethylammonium	application	resulted	in	an	initial	reduction	in	the	field	potential,	598 followed	by	a	long-lasting	increase	after	wash-out.	The	magnitude	of	the	599 tetraethylammonium-induced	LTP	was	unchanged	in	slices	of	TASTPM	compared	to	600 wild	type	animals	(data	not	shown).	This	confirms	that,	despite	deficits	in	tetanus-601 induced	LTP,	TASTPM	are	capable	of	expressing	LTP	under	other	induction	protocols.	602 	603 The	deficit	in	tetanus-induced	LTP	was	maintained	at	12	and	18	months	of	age	(Fig	4e).	604 	605 Synaptic	plasticity	in	TAS	and	TPM	mice	606 The	induction	of	LTP	was	also	examined	in	24	month	old	single	mutant	mice	(Fig	4f-h).	607 In	age-matched	wild	type	mice,	LTP	magnitude	was	similar	to	that	observed	at	younger	608 ages.		In	the	APPSwe	TAS	mice,	the	magnitude	of	LTP	was	smaller	than	wild	type	mice	(Fig	609 4f).		In	contrast,	in	the	PSEN1M146V	TPM	mice,	the	magnitude	of	LTP	was	greater	(Fig	4g).		610 There	was	an	overall	significance	between	genotypes	by	one-way	ANOVA	(p<0.05;	Fig	611 4h,	Fisher	LSD	post	hoc	tests	versus	wild	type	p=0.1	for	TAS	and	p=0.05	for	TPM).	612 
	613 
Cognition	and	behaviour	614 TASTPM	mice	show	rigidity	in	hippocampus-dependent	learning	615 The	hippocampus-dependent	forced-alternation	T-maze	task	was	used	to	assess	616 cognition	in	the	TASTPM	mice	at	three	ages	(Fig	5):	4	months,	which	corresponds	to	the	617 first	appearance	of	Αβ	plaques	(Fig	1)	and	where	tetanus	induced	LTP	was	first	impaired	618 (Fig	4);	8	months,	a	moderate	plaque	load	and	12	months,	a	heavy	plaque	load.	Due	to	619 availability	of	animals,	in	this	set	of	experiments,	the	4-month-old	group	was	run	as	620 three	cohorts	(no	significant	difference	between	the	cohorts);	while	the	8-	and	12-621 month-old	group	were	a	single	cohort	that	underwent	repeat	training	in	a	longitudinal	622 study.	It	should	be	noted	that	at	both	4	and	8	months	of	age,	a	subset	of	TASTPM	mice	623 did	not	complete	the	task	in	the	required	time	and	these	mice	were	not	included	in	the	624 final	results	(1	of	16	mice	at	4	months	of	age	and	3	of	13	mice	at	8	months	of	age).	625 	626 At	4	months	of	age,	both	genotypes	started	training	at	similar	levels	of	performance	and	627 improved	over	the	training	period	(Fig	5a,	two-way	ANOVA,	main	effect	of	5	block	628 training	period,	p=0·01).	However,	TASTPM	performed	significantly	worse	than	wild	629 type	mice	overall	(main	effect	of	genotype,	p<0·003),	and	there	was	no	significant	630 
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interaction	between	training	block	and	genotype.	Interestingly	in	Block	6,	after	2	days	631 without	training,	the	two	groups	came	together	with	almost	identical	performance	at	632 90%	correct	choices	(Fig	5a).	When	extra	delays	(2-6	minutes)	were	then	added	633 between	the	sample	and	choice	runs	a	slight	decrement	in	performance	occurred,	as	634 expected,	but	there	was	no	difference	between	genotypes	(Fig	5b).	In	terms	of	the	635 behaviour	within	the	trials	it	was	notable	that	on	both	the	sample	and	choice	runs	the	636 TASTPM	mice	showed	considerably	longer	response	times.	In	the	case	of	the	choice	run,	637 this	may	have	influenced	the	result,	especially	the	apparent	impairment	during	the	638 training	period,	as	the	time	that	memory	needed	to	be	retained	was	more	than	doubled	639 (Fig	5c).	640 	641 At	8	months	of	age,	TASTPM	performed	similarly	to	wild	type	mice,	improving	over	the	642 training	period	(two-way	ANOVA,	main	effect	of	training	period	(p<0·0001).	When	the	643 same	mice	that	were	run	at	8	months	were	retested	at	12	months	of	age,	wild	types	had,	644 as	expected,	returned	to	the	baseline	response	of	approximately	75%	correct	and	again	645 improved	from	~75%	to	~90%	during	the	training	period.	Unexpectedly	however,	646 TASTPM	appeared	to	have	retained	their	previous	training,	starting	the	training	at	647 ~90%	and	showed	no	further	improvement	over	the	training	period.	This	was	reflected	648 in	a	significant	interaction	between	training	period	and	genotype	in	a	two-way	ANOVA	649 (p<0·03,	Fig	5a).	650 	651 Animals	were	again	challenged	further	by	the	introduction	of	a	delay	between	sample	652 and	choice	runs	(Fig	5c).	While	at	8	months	there	was	no	difference	between	genotypes,	653 at	12	months	of	age	although	TASTPM	mice	showed	a	similar	decrement	with	the	654 longest	delays	their	performance	with	a	2·5	minute	delay	between	sample	and	choice	655 runs	was	surprisingly	better	than	their	wild	type	counterparts	(two-tailed	t-test,	656 p<0·05).	657 	658 Another	interesting	difference	between	the	12-month	mice	and	the	younger	groups	was	659 that	the	response	time	for	the	choice	run	for	TASTPM	mice	at	12	months	was	rapid	and	660 no	different	from	the	wild	type	mice	(Fig	5c).	(Note,	at	this	age	the	mice	also	always	661 completed	the	task	in	the	required	time.)	In	contrast,	as	described	for	4	months	above,	662 the	8-month-old	TASTPM	mice	showed	a	considerable	delay	to	respond.	However,	663 
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despite	this	delay	again	increasing	the	time	that	memory	needed	to	be	retained,	the	8	664 months	mice	showed	no	decrement	in	correct	choices.	665 	666 These	failures	and	delays	to	respond	may	be	interesting	in	terms	of	early	behavioural	667 changes	and	may	also	suggest	different	levels	of	anxiety.	668 	669 TASTPM	mice	show	decreased	activity	and	increased	anxiety-related	behaviour	670 compared	to	wild	type	mice.	671 In	the	light	of	the	behavioural	differences	seen	in	the	T-maze	trials,	locomotor	activity	672 and	anxiety	were	assessed	using	a	battery	of	tests.	First,	mice	were	placed	in	an	open	673 field	(Fig	6a).	TASTPM	mice	had	shorter	total	path	lengths	than	their	wild	type	674 counterparts	at	all	ages	(Fig.	6ai;	two-way	ANOVA,	main	effect	of	genotype,	p<0·0001;	no	675 interaction	between	age	and	genotype).	Furthermore,	TASTPM	mice	spent	more	time	in	676 the	peripheral	than	central	area	(Fig.	6aii;	two-way	ANOVA,	main	effect	of	genotype,	677 p<0·0005;	main	effect	of	age,	p<0·0001).	678 	679 Secondly,	at	8	months	of	age,	TASTPM	mice	spend	more	time	in	the	closed	than	open	680 arms	of	an	elevated	plus	maze	(two-way	ANOVA	interaction	between	age	and	genotype	681 p<0·05);	at	4	and	12	months	of	age	this	difference	was	not	evident	(Fig.	6b).	682 	683 Finally,	at	4	and	8	months	of	age,	TASTPM	mice	spent	more	time	in	the	closed	684 compartment	of	a	light/dark	box	(12	months	not	tested).	There	was	a	significant	685 interaction	between	age	and	genotype	(Fig.	6c;	p<0·05).	686 	687 Overall,	these	data	indicate	an	increased	level	of	anxiety	in	TASTPM	mice	from	early	688 stages	of	plaque	development	especially	at	earlier	ages.	 	689 
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Discussion	690 
Pathology	and	microglia	691 Proliferation	of	microglia,	particularly	clustering	around	plaques,	has	been	repeatedly	692 reported	in	Alzheimer’s	disease,	both	in	the	human	condition	and	in	mouse	models.[21-23]	693 Moreover	we	have	previously	reported	a	close	correlation	between	plaque	load	and	a	694 microglial	coexpression	module	in	TASTPM	mice.	This	reveals	not	only	changes	in	695 expression	of	the	gene	for	the	phagocytic	protein	CD68,	tested	with	696 immunohistochemistry	in	the	present	study	but	also	even	greater	changes	in	Trem2	697 expression,[10]	a	gene	shown	in	humans	to	be	important	in	Alzheimer’s	disease	in	698 GWAS.[24,	25]	However,	here	we	show	increased	density	of	microglia,	even	before	plaques	699 can	be	detected	in	this	mouse	model.	This	finding	required	immunohistochemistry	and	700 cell	counts	as	the	gene	expression	changes	of	such	specific	microglial	genes	would	only	701 be	apparent	in	whole	tissue	analysis	with	very	large	changes,	such	as	occurs	in	later	702 stages.	In	the	light	of	previous	reports,[21-23]	proliferation	seems	the	most	likely	703 explanation	of	the	increased	density,	although	other	causes	such	as	increased	survival	of	704 microglia	or	migration	into	the	hippocampus,	are	possible.	The	triggering	of	microglial	705 proliferation	may	be	due	to	soluble	Αβ	in	the	wider	neuropil,	as	seem	to	be	the	case	for	706 the	earliest	synaptic	changes.[16]	Alternatively,	it	is	possible	that	initial	seeds	of	plaques	707 are	already	present	at	this	early	stage	but	are	too	small	to	detect,	being	below	the	708 detection	threshold	set	here	(<10	µm2).	709 	710 In	either	case,	the	question	arises	as	to	how	plaque	development	then	continues	and	711 how	this	relates	to	increased	microglial	numbers	and	development	of	a	reactive	712 phagocytic	phenotype.	Once	plaques	are	seeded	at	these	early	stages,	the	ongoing	713 deposition	may	primarily	contribute	either	to	the	growth	of	plaques	or	to	the	seeding	of	714 new	plaques.	It	is	also	possible	that	large	plaques	are	not	the	result	of	smaller	plaques	715 growing	but	rather	due	to	the	fusion	of	smaller	plaques.	Here	we	observe	that	the	716 smallest	plaques	initially	increase	in	number,	almost	doubling	each	month.	This	rate	717 continues	to	increase,	albeit	not	quite	so	rapidly,	at	least	until	about	14	months	of	age	718 when	the	number	of	plaques	plateaus.	This	suggests	that	small	plaques	are	seeded	719 throughout	the	ages	tested	and	gradually	grow	to	form	the	larger	plaques.	Presumably	720 the	rapid	increase	in	the	seeding	of	plaques	during	the	early	stages	relates	to	the	rapid	721 increase	in	Aβ	levels	at	this	stage	that	we	have	previously	reported.[16]	The	plateauing	of	722 
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density	of	smaller	plaques	may	also	reflect	them	being	gradually	being	engulfed	as	the	723 larger	plaques	spread	and	thus	they	are	no	longer	seen	as	separate	entities.	This	is	724 strongly	suggested	by	the	appearance	of	brighter	spots	of	Aβ	in	the	halo	around	some	of	725 the	larger	plaques	as	can	be	seen	in	Fig	1a	from	10	months	onwards.	726 	727 As	plaques	form,	we	have	previously	shown	a	very	strong	correlation	with	microglial	728 gene	expression.[10]	This	encompasses	both	proliferation	and	activation	of	microglia.	729 While	there	are	more	microglia	very	early	in	these	Αβ	mice,	their	phagocytic	phenotype	730 appears	later	and	seems	only	to	be	triggered	once	the	larger	plaques	of	>500	µm2	731 develop.	However,	it	is	important	to	note	that	a	step	up	in	the	density	of	total	and	CD68	732 positive	microglia	also	occur	at	this	stage	in	the	wild	type	mice.	Although	the	number	of	733 microglia	and	their	activation	state	remains	higher	in	the	TASTPM	mice	the	similarity	in	734 the	timing	of	this	later	stage	in	both	genotypes	suggests	that	this	has	a	strong	age-735 related	component	rather	than	being	purely	dependent	on	the	presence	of	plaques.	736 However,	it	is	also	interesting	to	note	that	in	the	homozygous	TASTPM,	which	develop	737 plaques	earlier	but	plaque	load	plateaus	at	the	same	level	as	the	hemizygous	mice,	the	738 density	of	total	microglia	and	CD68	positive	microglia	is	higher	than	in	hemizygotes.	739 Furthermore,	the	absence	of	a	microglial	phenotype	in	the	TPM	mice,	while	the	TAS	mice	740 show	a	similar	phenotype	excludes	a	direct	effect	of	the	mutant	presenilin	on	microglial	741 function.	742 	743 As	has	been	previously	shown	in	TASTPM[10]	and	other	transgenic	mice	(for	example,	744 see	reference	22),	the	microglia	are	strongly	attracted	to	and	cluster	tightly	around	the	745 plaques	as	they	grow.	The	question	arises	as	to	what	the	microglia	are	actually	doing	in	746 the	Αβ	mice.	The	assumption	previously	has	been	that	they	are	removing	or	limiting	747 expansion	of	plaques.[22]	Conversely,	it	has	been	repeatedly	reported	that	removal	of	748 microglia	by	blocking	CSF1R	has	no	effect	on	plaque	load,[26-28]	although	a	role	for	749 microglia	in	initial	plaque	deposition	has	been	suggested,[29]	which	may	be	related	to	the	750 initial	early	rise	in	microglia	numbers,	even	preceding	detection	of	plaques.	It	is,	751 however,	clear	in	the	TASTPM	mice	that,	since	plaques	continue	to	grow	in	both	size	and	752 number	in	parallel	to	rapid	microglial	proliferation,	it	does	not	seem	that	microglia	are	753 very	effective	at	removing	Aβ.	Recently	interesting	evidence	has	been	presented	that	Aβ	754 stimulates	microglia	to	phagocytose	synapses	in	a	complement	dependent	manner	at	755 
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early	stages	of	plaque	development	in	J20	(APPSwe/Ind)	mice[30]	leading	to	the	hypothesis	756 that	microglia	are	causing	early	synaptic	damage.	We	put	forward	an	alternative	757 hypothesis	that	the	microglia	are	rather	removing	spines	and	boutons	damaged	by	the	758 high	levels	of	soluble	Αβ	in	or	near	the	plaques	and	that	this	may	represent	a	protective	759 function,	avoiding	further	damage	to	the	dendrites	and	axons	affected	and	hence	760 protecting	network	function.	This	is	further	supported	by	the	observation	that	as	761 plaques	grow	synaptic	loss	is	concentrated	near	to	the	plaques	and	the	loss	decreases	762 further	from	plaques.[31,	32]	763 	764 
Synaptic	transmission	765 At	8	months	of	age	the	synaptic	changes	observed	are	almost	identical	to	those	we	have	766 previously	reported	at	4	months,	with	no	change	in	miniature	currents	but	a	complete	767 loss	of	spontaneous	activity	and	an	increase	in	release	probability	of	glutamate.	768 Particularly	at	early	stages,	the	plaque	load	in	terms	of	the	percentage	tissue	coverage	is	769 very	low	and	so	very	few	of	the	synapses	recorded	would	be	close	to	a	plaque.	Moreover,	770 the	observation	that	the	change	in	paired-pulse	ratio	is	similar	despite	a	rising	plaque	771 load	also	suggests	that	the	plaques	themselves	are	unlikely	to	be	causing	this	effect.	772 Hence,	this	is	presumably	the	result	of	very	low	levels	of	soluble	Αβ	throughout	the	773 tissue.	Increased	release	probability	has	been	reported	to	be	the	physiological	effect	of	774 Αβ	release	in	wild	type	rats.[5]	As	the	plaque	load	increases	and	larger	plaques	start	to	775 appear,	additional	changes	become	evident.	At	12	months,	although	the	evoked	release	776 probability	is	still	similarly	affected,	being	higher	in	the	transgenic	mice	than	the	wild	777 type	mice,	there	is	also	a	reduction	in	the	frequency	of	miniature	EPSCs.	The	simplest	778 interpretations	of	loss	of	miniature	frequency	is	either	a	loss	of	functional	synapses	or	a	779 decreased	release	probability	(see	reference	33	for	review).	As	we	have	demonstrated	780 that	release	probability	is	increased,	this	suggests	that	there	is	a	loss	synapses	is	the	781 likely	explanation.	In	and	around	the	plaques	soluble	and	insoluble	Αβ	will	be	in	782 equilibrium	and	with	increased	plaque	coverage	with	age,	at	least	some	of	the	synapses	783 will	be	directly	affected	by	the	high	local	concentration	of	Αβ	in	the	close	vicinity	of	a	784 plaque	which	could	lead	to	this	loss.	Note	that	unlike	evoked	currents,	miniature	785 synaptic	currents	can	originate	from	any	synapse	in	the	tissue	and	hence	some	will	be	786 physically	near	plaques.	The	increasing	effect	as	the	plaque	load	rises,	supports	this	787 hypothesis.	This	is	again	consistent	with	the	observation	that	synaptic	loss	occurs	with	788 
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increased	plaque	load	but	that	the	loss	is	inversely	proportional	to	distance	from	a	789 plaque.[31]	790 	791 It	is	notable	that	the	decrease	in	frequency	of	miniature	EPSCs	observed	at	12	months	792 coincides	with	the	increase	in	microglial	number	and	activation	but	that	it	does	not	793 decrease	any	further	by	18	months.	This	is	consistent	with	the	plaque	load	and	indeed	794 the	microglial	density	largely	plateauing	by	14	months.	The	very	effective	microglial	795 proliferation	and	subsequent	phagocytic	phenotype,	associated	with	strong	796 upregulation	of	microglial	genes	such	as	Trem2	that	we	have	previously	reported	at	this	797 age,[10]	may	be	one	of	the	reasons	why	the	progression	of	Alzheimer’s	pathology	to	798 neurofibrillary	tangles	and	neurodegeneration	does	not	go	further	in	these	mice.	799 	800 
Synaptic	plasticity	801 The	biphasic	change	in	LTP	induced	by	a	mild	tetanic	stimulus	at	the	early	stages	of	802 pathology	in	Αβ	mice	is	of	interest.	At	2	months	of	age,	prior	to	detection	of	plaques,	803 when	LTP	is	enhanced	in	the	Αβ	mice,	Aβ	is	certainly	present,	albeit	at	low	levels.[10,	16]	804 By	4	months	of	age,	when	the	first	plaques	are	evident,	Aβ	levels	are	at	least	10-fold	805 higher	than	at	2	months.	At	this	stage	the	opposite	effect	is	observed	with	magnitude	of	806 tetanus-induced	LTP	much	reduced	compared	to	wild	types.	This	LTP	deficit	was	807 maintained	both	at	12	and	18	months	of	age.	The	biphasic	pattern	of	change	may	reflect	808 the	increasing	glutamate	release	probability	which	we	have	previously	shown	is	greater	809 at	4	months	than	at	2	months	of	age.	If	glutamate	were	more	readily	released	during	810 conditioning,	the	initial	outcome	may	be	a	greater	calcium	influx	through	NMDA	811 receptors	and	thus	a	larger	magnitude	LTP.	However,	as	levels	rise	by	4	months	and	812 release	probability	increases	further,	depletion	of	the	readily-releasable	pool	of	synaptic	813 vesicles	during	the	first	pulses	of	the	conditioning	train	may	result	in	a	failure	to	release	814 transmitter	as	the	train	continues,	thus	impairing	LTP.	Alternatively,	the	higher	levels	of	815 Aβ	may	have	other	effects,	interacting	with	NMDA	receptors	directly	and	impeding	LTP	816 (reviewed	in	reference	34).	Moreover,	Aβ	is	itself	proposed	to	be	released	in	an	activity-817 dependent	manner[35-37]	and	hence,	as	its	levels	rise,	resulting	in	increased	release	818 probability,	this	could	lead	to	a	positive	feedback.	819 	820 
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In	concert	with	(or	alternatively	to)	the	direct	physiological	effects	of	low	levels	of	Aβ,	821 the	early	increase	in	LTP	magnitude	we	report	could	be	an	interaction	with	the	mutant	822 presenilin	1.	Expression	of	both	normal	and	mutant	presenilin	1	has	direct	effects	on	823 synaptic	transmission	and	plasticity.	For	example,	the	A246E	mutation	leads	to	824 increased	LTP	magnitude	at	young	ages,[38,	39]	while	the	L286V	mutation	increases	LTP	825 magnitude	at	young	ages	but	decreases	at	older	(14	month)	ages.[40]	Here	we	show	that	826 the	M146V	mutation	increases	the	magnitude	of	LTP	at	24	months	of	age,	which	could	827 be	the	underlying	mechanism	of	the	initial	increased	LTP	observed	in	the	TASTPM,	until	828 the	later	Aβ	effects	become	dominant,	decrementing	the	LTP.	829 	830 Interestingly	when	theta	burst	stimulation	was	used	for	induction,	during	which	the	831 readily-releasable	pool	would	have	a	chance	to	replenish,	there	was	no	significant	deficit	832 in	LTP	at	4	months.	However,	under	these	conditions	at	2	months,	we	see	a	decrease	in	833 paired-pulse	ratio	following	induction	of	LTP	that	remains	throughout	the	experiment,	834 indicating	an	increase	in	release	probability.	As	outline	above,	the	physiological	effect	of	835 Aβ	is	to	increase	release	probability,	and	so	this	suggests	that	the	theta	rhythm	itself	836 may	be	causing	local	release	of	Αβ	at	the	stimulated	synapses.	Despite	this	apparent	837 presynaptic	increase	in	transmission,	the	magnitude	of	LTP	remains	unaltered,	raising	838 the	possibility	of	a	postsynaptic	decrease	balancing	this	effect.	However,	when	TEA	was	839 applied	to	slices,	resulting	in	a	wide-spread	depolarisation	and	thus	release	of	all	840 neurotransmitter	vesicles	(excitatory,	inhibitory	and	modulatory),	LTP	was	induced	841 similarly	to	wild	types	confirming	that	some	forms	of	long-term	plasticity	remain	intact.	842 In	our	hands,	the	locus	of	expression	of	LTP,	induced	by	tetanus,	tends	to	have	a	843 presynaptic	component	in	both	genotypes,	indicated	by	a	change	in	paired-pulse	profile	844 following	induction.	845 	846 
Behaviour	847 In	this	study,	TASTPM	mice	showed	no	measurable	cognitive	deficits	at	any	age,	despite	848 a	substantial	plaque	load.	849 	850 There	were,	however,	clear	differences	in	motor	activity	and	anxiety	related	behaviours.	851 The	TASTPM	mice	were	slower	to	perform	the	T-maze	task	than	the	wild	type	mice	or	852 failed	to	do	so	altogether.	Furthermore,	in	other	tests,	decreased	activity	and	increased	853 
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anxiety	were	evident.	Although	not	specifically	measured,	the	TASTPM	mice	are	also	854 more	aggressive	than	wild	type	mice.[41]	855 	856 The	improved	retention	of	learning	in	TASTPM	mice,	requiring	no	repeat	training	when	857 the	same	mice	were	tested	twice	at	8	and	12	months,	may	appear	counterintuitive.	858 However,	similar	outcomes	in	hippocampal	learning	have	been	reported	in	TASTPM	859 mice	at	around	4	months,	using	a	contextual	fear	conditioning	regime.	While	mice	were	860 unimpaired	in	learning	the	task	in	these	previous	reports,	they	failed	to	extinguish	their	861 learnt	fear	behaviour	when	conditioning	was	reversed.[13,	14,	42]	In	the	present	study,	the	862 difference	was	additionally	noted,	with	the	TASTPM	mice	also	making	more	correct	863 choices	than	the	wild	type	mice	when	a	delay	between	runs	was	introduced.	864 	865 The	subtlety	of	the	cognitive	changes	reported	here	in	the	TASTPM	mouse,	even	at	866 stages	where	a	heavy	plaque	load	is	present,	is	consistent	with	previous	findings.[13-15,	42]	867 Even	when	other	Αβ	models	are	considered,	cognitive	deficits	are	limited	and,	where	868 present,	it	is	unclear	how	they	truly	translate	to	the	human	disease	(for	reviews,	see	869 references	43,	44).	Moreover,	this	is	consistent	with	the	human	condition,	where,	at	the	870 time	of	diagnosis,	when	cognitive	deficits	are	first	being	detected,	there	is	already	a	871 substantial	reduction	in	hippocampal	volume	of	up	to	20%,[45]	whereas	there	is	no	872 apparent	neuronal	loss	in	TASTPM	mice.	Furthermore,	in	humans,	cognitive	decline	873 correlates	well	with	Tau	PET	markers	and	less	with	Aβ	load.[46]	Given	that	Αβ	mouse	874 models	are	not	a	complete	model	of	AD,	i.e.	lacking	Tau	tangle	formation	and	875 neurodegeneration,	which	more	faithfully	correlate	with	cognitive	decline,	they	should	876 be	considered	as	models	of	the	preclinical	disease,	when	Αβ	is	first	deposited.	877 	878 Here	we	bring	together	the	progression	of	pathology,	microglia,	synaptic	transmission	879 and	other	functional	changes	in	a	preclinical	mouse	model	of	AD.	In	a	following	paper	we	880 compare	these	results	in	mice	with	only	plaques	and	no	neurofibrillary	tangles	to	a	881 transgenic	mouse	model	of	later	stage	dementia	in	which	neurofibrillary	tangles	occur	882 without	plaques.[47]	883 	884 From	the	present	study	we	conclude	that	the	earliest	effects	of	Αβ	on	synaptic	885 transmission	are	probably	due	to	very	low	levels	of	soluble	Αβ	in	the	volume	of	the	886 
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tissue,	rather	than	being	directly	related	to	plaques.	At	this	early	stage	plaques	are	887 extremely	small	and	sparse	so	that	they	would	impinge	directly	on	very	few	synapses.	888 However,	while	wide-spread	soluble	Αβ	may	also	influence	early	microglial	changes	889 these	may	well	be	influenced	by	the	earliest	seeding	of	plaques.	Later	changes	most	890 probably	relate	to	the	increasing	numbers	of	larger	plaques	with	the	cloud	of	high-level	891 soluble	Αβ	surrounding	them	impinging	on	a,	still	limited,	but	much	greater	area.	The	892 direct	effects	of	this	localised	high	concentration	of	soluble	Αβ	include	loss	of	active	893 synapses	and	activation	of	microglia,	likely	involved	in	clearing	damaged	synapses	near	894 or	within	plaques	via	phagocytosis	and	thus	preventing	wider	damage	to	the	affected	895 axons	and	dendrites.	While	seeding	of	new	plaques	seems	to	continue	throughout	the	896 development	of	plaque	pathology,	it	is	only	once	large	plaques	are	present	that	these	897 latter	changes	occur.	Moreover,	the	lack	of	cognitive	deficits	is	similar	to	the	human	898 situation	prior	to	the	build-up	of	neurofibrillary	tangles	and	neurodegeneration	and	thus	899 suggests	that	TASTPM	represent	a	good	model	of	the	prodromal	phase	of	the	disease.	 	900 
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Figure	1	Plaque	development	in	TASTPM	mice	1088 a)	Representative	micrographs	of	Aβ40	(green)	immunofluorescence	in	hippocampus	1089 from	3-	to	15-month-old	hemizygous	TASTPM	mice.	Scale	bar	250	μm.	b)	Plaque	density	1090 measured	at	different	ages	in	TASTPM	mice	(n=2-3	animals	per	age	group).	c)	1091 Proportion	of	plaques	of	indicated	sizes	contributing	to	increased	percentage	coverage	1092 of	the	hippocampus	with	increased	age.	d)		Density	of	plaques	within	specific	size	ranges	1093 (as	indicated	on	x-axes)	over	age	(colours	as	indicated	in	key).	The	inset	covers	smaller	1094 bin	sizes	for	plaques	up	to	200	μm2.	Note	the	split	y-axes.	e)	Density	of	homozygous	1095 TASTPM	plaques	within	specific	size	ranges	(as	indicated	on	x-axes)	over	age	(colours	as	1096 indicated	in	key).	f)	Density	of	TAS	plaques	within	specific	size	ranges	(as	indicated	on	x-1097 axes)	over	age	(colours	as	indicated	in	key).	Note	the	different	x	and	y-axes	in	f	1098 compared	to	d	and	e,	with	few	plaques	and	maximum	plaque	area	under	500	μm2.	All	1099 data	are	represented	by	mean±SEM.	 	1100 
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Figure	2	Microglial	proliferation	and	activation	in	TASTPM	mice	1102 a)	Microglia	(Iba1,	green)	cluster	around	plaques	(Aβ1-40,	red)	in	TASTPM	mouse	1103 hippocampus	(nuclei:	DAPI,	blue).	Scale	bar	250	μm.	b)	Examples	of	phagocytic	1104 microglia	(CD68,	red	+	Iba1,	green;		yellow	when	colocalised)	in	wild	type	and	TASTPM	1105 hippocampus.	Scale	bar	25	μm.	c)	Total	microglial	density	(Iba1+,	full	bar	height)	and	1106 phagocytic	microglial	(Iba1	+	CD68+,	black	bar)	density	in	hemizygous	TASTPM	mice	1107 with	age.	Sigmoidal	fits	are	shown	(Iba1	green;	CD68	red):	unbroken	lines,	TASTPM;	1108 dashed	lines,	wild	type	(only	fit	shown	for	wild	type).	d)	Total	and	phagocytic	microglial	1109 densities	in	homozygous	TASTPM	mice	with	age.	Sigmoidal	fits	are	shown.	e)	Total	and	1110 phagocytic	microglial	densities	in	the	APPSwe	TAS	mice	at	the	ages	shown.	Significant	1111 main	effects	of	genotype	for	both	IBA1	and	CD68	are	indicated	by	*p<0.05.	f)	Densities	of	1112 total	microglia	and	CD68	positive	phagocytic	microglia	in	4	month	old	PSEN1M146V	TPM	1113 microglia.	All	data	are	represented	by	mean±SEM.	 	1114 
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Figure	3	Excitatory	and	inhibitory	synaptic	transmission	in	TASTPM	mice	1116 ai)	Example	spontaneous	and	miniature	EPSCs	recorded	from	18-month-old	TASTPM.		1117 aii)	Frequency	of	spontaneous	EPSCs.	Main	effect	of	genotype	by	2-way	ANOVA	1118 (p=0.0011).	aiii)	Frequency	of	miniature	EPSCs.	Main	effect	of	genotype	by	2-way	1119 ANOVA	(p	<	0.01)		bi)	Example	responses	evoked	by	paired	stimuli.	bii)	Paired-pulse	1120 ratios	from	12-month-old	mice.	Main-effect	of	genotype	by	2-way	ANOVA	(p=0.02).	(biii)	1121 Paired-pulse	ratios	from	18-month-old	mice.	Genotype	by	inter-stimulus	interval	1122 interaction	(p<0.05);	Sidak	post-hoc	test	is	indicated	(p=0.002).	ci)	Example	continuous	1123 recordings	of	spontaneous	IPSCs.	cii)	Spontaneous	IPSC	frequencies.	Sample	sizes	are	1124 indicated	by	the	numbers	within	bars	or	within	parentheses.	*	p<0.05;	**	p<0.01.	All	1125 data	are	represented	by	mean±SEM.	 	1126 
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Figure	4	Field	EPSP	recordings	of	synaptic	plasticity	in	TASTPM	mice	1128 a-c)	2	months	upper	row;	4	months	lower	row.	a)	Input-output	relationship,	b)	Paired-1129 pulse	ratio	profile	and	c)	Time	course	of	tetanus-induced	LTP:	fEPSP	(upper	panels)	and	1130 paired-pulse	ratio	(PPR,	lower	panels)	after	induction	as	a	percentage	of	pre-induction	1131 baseline.	Traces	are	representative	fEPSPs	from	baseline	(grey)	and	the	51-60	minutes	1132 after	tetanus	(black).	Scale	bars:	5	ms	x	0.5	mV.	d)	Magnitude	of	LTP	(left)	induced	by	1133 tetanus	over	2-18	months	of	age	(number	of	mice	as	indicated	in	each	column).	Two-1134 way	ANOVA	revealed	significant	age	x	genotype	interaction	(P<0.0001).	Change	in	1135 paired-pulse	ratio	(right)	following	LTP	induction.	Both	wild	type	and	TASTPM	mice	1136 showed	a	significant	decrease	in	PPR	compared	to	baseline	at	both	ages	(paired	t-tests	1137 within	separate	experiments;	p	<	0.05).	No	significant	difference	between	genotypes	1138 (two-way	ANOVA).	e)	Magnitude	of	LTP	induced	by	theta-burst	stimulation	(left,	no	1139 significant	difference	between	genotypes)	and	corresponding	change	in	paired-pulse	1140 ratio	(right;	two-way	ANOVA	age	x	genotype	interaction	p	<	0.05).	Sidak	post	hoc	test:	1141 *P<0.05;	****P<0.0001.	f)	LTP	induced	by	tetanic	stimulation	in	APPSwe	TAS	mice	at	24	1142 months	of	age.	g)	LTP	induced	by	tetanic	stimulation	in	PSEN1M146V	TPM	mice	at	24	1143 months.		Wild	type	animals	are	common	to	both	panels	f	and	g.	h)	Magnitude	of	LTP	1144 induced	in	24	month	old	wild	type,	TAS	and	TPM	mice.		24	month	old	recordings	for	all	1145 genotypes	were	interleaved;	significance	tested	by	one-way	ANOVA,	*p<0.05.	All	data	1146 are	represented	by	mean±SEM.	 	1147 
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Figure	5	Hippocampus-dependent	T-Maze	learning	in	TASTPM	mice	1149 a-c)	Ages	as	indicated	above	panel	a.		a)	Probability	of	mice	making	a	correct	choice	in	1150 the	choice	run	at	4	months	(n=15-16	animals	completing	the	task),	8	months		(n=10-13	1151 animals	completing	the	task)	and	12	months	of	age	(wild	type	n=15;	TASTPM	n=8).	At	4	1152 months	of	age	there	was	a	main	effect	of	genotype	in	a	two-way	ANOVA	(§§	p<0.01).	1153 Note	the	difference	in	starting	performance	at	12	months	of	age.	These	are	the	same	1154 mice	tested	at	8	months.	As	expected	wild	type	mice	started	at	around	75%	correct	1155 choices	and	improved	with	training	having,	extinguished	their	previous	training.	1156 TASTPM	mice	unexpectedly	started	training	making	correct	choices	90%	of	the	time	1157 having	retained	the	previous	improved	level.	Two-way	ANOVA	interaction	between	1158 training	block	and	genotype	(p<0.03);	Sidak	post	hoc	analyses	are	indicated	by	*P<0.05,	1159 **P<0.01.	b)		The	introduction	of	delays	between	sample	and	choice	runs	revealed	no	1160 further	differences	between	genotypes	at	4	or	8	months	of	age,	while	at	12	months,	a	1161 significant	effect	of	genotype	was	observed	with	TASTPM	mice	retaining	performance	1162 despite	a	2.5	minute	delay	before	the	choice	run	(†	p<0.05).	c)		Response	time	for	choice	1163 run	at	4	-12	months	of	age,	Sidak	post	hoc	analyses	are	indicated	by	*P<0.05,	**P<0.01,	1164 ***P<0.001,	****P<0.0001.	All	data	are	represented	by	mean±SEM.	 	1165 
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Figure	6	Open	field	and	tests	of	anxiety	1168 a)	Open	field	test.	ai)	Total	path	length	run	over	30	mins.	Main	effect	of	genotype	by	two-1169 way	ANOVA	(§§§	p<0.001).	aii)	Time	spent	in	peripheral	area.	Main	effect	of	genotype	by	1170 two-way	ANOVA	(§§§§	p<0.0001).	b)	Elevated	plus	maze.	Relative	time	in	closed	arm.	c)	1171 Light/dark	box.	Relative	time	spent	in	dark	compartment	(12	months	not	tested.)		In	b	1172 and	c,	Sidak	post	hoc	tests	are	indicated	(two-way	ANOVA	genotype	x	age	interaction	1173 P<0.05;	*	p<0.05;	***p<0.001;	****	p<0.0001).	All	data	are	represented	by	mean±SEM. 	1174 
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Table	1:	Antibodies	used	for	immunohistochemistry:	1175 
Antibody		 Dilution	 Source	 RRID	IBA1	 1:500	 Wako	(019-19741)	 AB_839504	CD68	 1:500	 BioRad	(MCA1957)	 AB_322219	Aβ1-40	 1:300	 ThermoFisher	(44-136)	 AB_2533599		1176 
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